WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched on MAY 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

ANTICHOLESTEROL ACTIVITY OF AJU MBAISE

Johnson-Ajinwo Okiemute Rosa* and Sweetmoreton Weene Simon

ABSTRACT

Obesity is a growing health concern worldwide and is referred to as the „menace of obesity?. It is linked to variousdiseases and can lead to a decrease in quality of life. This study focuses on the use of the Aju Mbaise, a local herbcombination, in aiding weight loss. Also, one of the objectives of this study is to determine the component orcomponents responsible for the Aju Mbaise weight loss activity. Thirty-two rats of both sexes were used anddivided into eight groups. The first group was fed with standard diet as the negative control. The last group wasdosed with atorvastatin as the positive control and the rest groups of rats were dosed with Aju Mbaise and itscomponent parts. Phytoconstituent extraction of the Aju Mbaise was carried out using methanol anddichloromethane as solvents. Phytochemical screening and GCMS analysis was undertaken to determine theclasses of compounds contained in the Aju Mbaise. Serological testing to determine plasma levels of HighDensity Lipoprotein, Low Density Lipoprotein, total cholesterol and triglycerides was carried out. The weights ofthe animals were monitored for 21 days. Also, GC-MS Analysis to determine the bioactive compounds wascarried out. The data was analyzed by one-way analysis of variance and Duncan?s Post Hoc test. There wasmarked weight loss by Ceiba pentandra, the mixture of Barteria fistulosa and Napoleona vogelli as well asUvaria chamae at P< 0.05. GC-MS analysis revealed 7-Nonenoic acid, methyl ester, 8-Nonynoic acid and 2-Piperidinone, N-[4-Bromo-n-butyl]- which have been reported for antibacterial activity. Additionally, 8-Nonynoicacid is known to inhibit the synthesis of fatty acids. Serological results showed optimum levels of Triglyceridesand Very Low Density Lipoprotein, while plasma levels of High Density Lipoprotein, Low Density Lipoproteinand total cholesterol were moderate.

[Full Text Article] [Download Certificate]